Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Conditions
- Testicular Cancer
- Germ Cell Neoplasm
Interventions
- DRUG: paclitaxel, gemcitabine, and oxaliplatin
Sponsor
University of Southern California
Collaborators